Literature DB >> 22279515

Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology.

Panga Jaipal Reddy1, Rekha Jain, Young-Ki Paik, Robin Downey, Adam S Ptolemy, Vural Ozdemir, Sanjeeva Srivastava.   

Abstract

Year:  2011        PMID： 22279515      PMCID： PMC3264661          DOI： 10.2174/187569211794728850

Source DB:  PubMed          Journal:  Curr Pharmacogenomics Person Med        ISSN： 1875-6913


× No keyword cloud information.
  41 in total

Review 1.  Protein microarrays and novel detection platforms.

Authors:  Harini Chandra; Panga Jaipal Reddy; Sanjeeva Srivastava
Journal:  Expert Rev Proteomics       Date:  2011-02       Impact factor: 3.940

Review 2.  Proteogenomics and systems biology: quest for the ultimate missing parts.

Authors:  Jean Armengaud
Journal:  Expert Rev Proteomics       Date:  2010-02       Impact factor: 3.940

Review 3.  Steering vaccinomics innovations with anticipatory governance and participatory foresight.

Authors:  Vural Ozdemir; Samer A Faraj; Bartha M Knoppers
Journal:  OMICS       Date:  2011-08-17

4.  Nutriproteomics and Proteogenomics: Cultivating Two Novel Hybrid Fields of Personalized Medicine with Added Societal Value.

Authors:  Vural Ozdemir; Jean Armengaud; Laurette Dubé; Ramy Karam Aziz; Bartha M Knoppers
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-12-01

5.  SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.

Authors:  Manoj Kumar Kashyap; H C Harsha; Santosh Renuse; Harsh Pawar; Nandini A Sahasrabuddhe; Min-Sik Kim; Arivusudar Marimuthu; Shivakumar Keerthikumar; Babylakshmi Muthusamy; Kumaran Kandasamy; Yashwanth Subbannayya; Thottethodi Subrahmanya Keshava Prasad; Riaz Mahmood; Raghothama Chaerkady; Stephen J Meltzer; Rekha V Kumar; Anil K Rustgi; Akhilesh Pandey
Journal:  Cancer Biol Ther       Date:  2010-10-15       Impact factor: 4.742

6.  2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.

Authors:  Pooja Pal; Jitendra K Kanaujiya; Savita Lochab; Shashi B Tripathi; Madan L B Bhatt; Pradhyumna K Singh; Sabyasachi Sanyal; Arun K Trivedi
Journal:  Proteomics       Date:  2011-02-25       Impact factor: 3.984

7.  Comparative proteomic analysis of differentially expressed proteins in primary retinoblastoma tumors.

Authors:  Kandalam Mallikarjuna; Curam Sreenivasacharlu Sundaram; Yogendra Sharma; Perinkulam Ravi Deepa; Vikas Khetan; Lingam Gopal; Jyotirmay Biswas; Tarun Sharma; Subramanian Krishnakumar
Journal:  Proteomics Clin Appl       Date:  2010-01-04       Impact factor: 3.494

8.  Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes.

Authors:  Shraddha Kumari Gupta; Brijesh Singh Sisodia; Sudhir Sinha; Krishnan Hajela; Sita Naik; Ajit Kumar Shasany; Anuradha Dube
Journal:  Proteomics       Date:  2007-03       Impact factor: 3.984

9.  Proteomics indicates modulation of tubulin polymerization by L-menthol inhibiting human epithelial colorectal adenocarcinoma cell proliferation.

Authors:  Uzma Faridi; Brijesh S Sisodia; Ashutosh K Shukla; Rakesh K Shukla; Mahendra P Darokar; Upendra N Dwivedi; Ajit K Shasany
Journal:  Proteomics       Date:  2011-04-07       Impact factor: 3.984

10.  Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B.

Authors:  Poonam Gautam; Jata Shankar; Taruna Madan; Ravi Sirdeshmukh; Curam Sreenivasacharlu Sundaram; Wasudev Namdeo Gade; Seemi Farhat Basir; Puranam Usha Sarma
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191
View more
  7 in total

1.  End of the Beginning and Public Health Pharmacogenomics: Knowledge in 'Mode 2' and P5 Medicine.

Authors:  Vural Ozdemir; Erik Fisher; Edward S Dove; Hilary Burton; Galen E B Wright; Mario Masellis; Louise Warnich
Journal:  Curr Pharmacogenomics Person Med       Date:  2012-01-01

2.  Personalized Medicine in a New Genomic Era: Ethical and Legal Aspects.

Authors:  Maria Shoaib; Mansoor Ali Merchant Rameez; Syed Ather Hussain; Mohammed Madadin; Ritesh G Menezes
Journal:  Sci Eng Ethics       Date:  2016-11-28       Impact factor: 3.525

3.  Public Health Pharmacogenomics and the Design Principles for Global Public Goods - Moving Genomics to Responsible Innovation.

Authors:  Vural Ozdemir; Alexander Borda-Rodriguez; Edward S Dove; Lynnette R Ferguson; Farah Huzair; Vangelis G Manolopoulos; Mario Masellis; Djims Milius; Louise Warnich; Sanjeeva Srivastava
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-03-24

4.  A Mobilising Concept? Unpacking Academic Representations of Responsible Research and Innovation.

Authors:  Barbara E Ribeiro; Robert D J Smith; Kate Millar
Journal:  Sci Eng Ethics       Date:  2016-03-08       Impact factor: 3.525

5.  Towards an Ecology of Collective Innovation: Human Variome Project (HVP), Rare Disease Consortium for Autosomal Loci (RaDiCAL) and Data-Enabled Life Sciences Alliance (DELSA).

Authors:  Vural Ozdemir; David S Rosenblatt; Louise Warnich; Sanjeeva Srivastava; Ghazi O Tadmouri; Ramy K Aziz; Panga Jaipal Reddy; Aresha Manamperi; Edward S Dove; Yann Joly; Ma'n H Zawati; Candan Hızel; Yasemin Yazan; Leela John; Emmanuelle Vaast; Adam S Ptolemy; Samer A Faraj; Eugene Kolker; Richard G H Cotton
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12-01

6.  Ethical, Political and Societal Implications of the Open Access Journal Movement in the Era of Economic Crisis, with Emphasis on Public Health Pharmacogenomics.

Authors:  Nicola Luigi Bragazzi
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-12

Review 7.  "Omics"-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives.

Authors:  Holly Matthews; James Hanison; Niroshini Nirmalan
Journal:  Proteomes       Date:  2016-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.